Rush University Medical Center

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR) , a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois . To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology .

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Key	Description
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
185	Complete Reporting: Results based on 5 months reporting

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR) . Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Key	Description
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
185	Complete Reporting: Results based on 5 months reporting

Adult CLABSI

Pediatric CLABSI

NICU CLABSI

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR) . Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure ( CABG , KPRO ) and hospital are also included.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Key	Description
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
185	Complete Reporting: Results based on 5 months reporting

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare . This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare .

Measure	Result
Healthcare workers given influenza vaccination Q4 2022 - Q1 2023 Result 98.00 %	98.00 %
Description Influenza Vaccination Coverage among Healthcare Personnel Historical Data
Measure	Result
Q4 2021 - Q1 2022 Result 97.00 %	97.00 %
Q4 2020 - Q1 2021 Result 99.00 %	99.00 %
Q4 2019 - Q1 2020 Result 97.00 %	97.00 %
Q4 2018 - Q1 2019 Result 98.00 %	98.00 %
Q4 2017 - Q1 2018 Result 96.00 %	96.00 %

Illinois Hospital Report Card

and Consumer Guide to Health Care

Rush University Medical Center

Patient Safety - All

Healthcare-Associated Infections

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Statistical Significance

Description

Historical Data

Description

Historical Data

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Adult CLABSI

Description

Historical Data

Description

Historical Data

Description

Historical Data

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Surgical Site Infections (SSIs)

Statistical Significance

Description

Historical Data

Description

Historical Data

Immunization Practices

Immunization

Description

Historical Data

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2024 - Q4 2024 Result 3 infections, 158839 patient days Rating SIR: 0.37	3 infections, 158839 patient days	0.37
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 11 infections, 158342 patient days Rating SIR: 1.15	11 infections, 158342 patient days	1.15
Q1 2022 - Q4 2022 Result 10 infections, 156953 patient days Rating SIR: 1.28	10 infections, 156953 patient days	1.28
Q1 2021 - Q4 2021 Result 8 infections, 160965 patient days Rating SIR: 1.04	8 infections, 160965 patient days	1.04
Q1 2020 - Q4 2020 Result 12 infections, 157040 patient days Rating SIR: 1.60	12 infections, 157040 patient days	1.60
Q1 2019 - Q4 2019 Result 5 infections, 161796 patient days Rating SIR: 0.65	5 infections, 161796 patient days	0.65
Q1 2018 - Q4 2018 Result 11 infections, 159640 patient days Rating SIR: 1.28	11 infections, 159640 patient days	1.28
Q1 2017 - Q4 2017 Result 8 infections, 154169 patient days Rating SIR: 0.89	8 infections, 154169 patient days	0.89
Q1 2016 - Q4 2016 Result 4 infections, 158229 patient days Rating SIR: 0.52	4 infections, 158229 patient days	0.52
Q1 2015 - Q4 2015 Result 8 infections, 163565 patient days Rating SIR: 0.66	8 infections, 163565 patient days	0.66
Q1 2014 - Q4 2014 Result 8 infections, 178175 patient days Rating SIR: 0.53	8 infections, 178175 patient days	0.53
Q1 2013 - Q4 2013 Result 5 infections, 172248 patient days Rating SIR: 0.35	5 infections, 172248 patient days	0.35
Q1 2012 - Q4 2012 Result 10 infections, 179167 patient days Rating SIR: 0.70	10 infections, 179167 patient days	0.70
Q1 2012 - Q2 2012 Result 6 infections, 90361 patient days Rating SIR: 0.66	6 infections, 90361 patient days	0.66
Clostridioides difficile infections (CDI) Q1 2024 - Q4 2024 Result 63 infections, 138502 patient days Rating SIR: 0.57	63 infections, 138502 patient days	0.57
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 58 infections, 136271 patient days Rating SIR: 0.53	58 infections, 136271 patient days	0.53
Q1 2022 - Q4 2022 Result 58 infections, 139063 patient days Rating SIR: 0.54	58 infections, 139063 patient days	0.54
Q1 2021 - Q4 2021 Result 84 infections, 143160 patient days Rating SIR: 0.73	84 infections, 143160 patient days	0.73
Q1 2020 - Q4 2020 Result 65 infections, 139049 patient days Rating SIR: 0.59	65 infections, 139049 patient days	0.59
Q1 2019 - Q4 2019 Result 53 infections, 142270 patient days Rating SIR: 0.46	53 infections, 142270 patient days	0.46
Q1 2018 - Q4 2018 Result 69 infections, 144286 patient days Rating SIR: 0.61	69 infections, 144286 patient days	0.61
Q1 2017 - Q4 2017 Result 131 infections, 138139 patient days Rating SIR: 1.16	131 infections, 138139 patient days	1.16
Q1 2016 - Q4 2016 Result 142 infections, 141808 patient days Rating SIR: 1.29	142 infections, 141808 patient days	1.29
Q1 2015 - Q4 2015 Result 138 infections, 149707 patient days Rating SIR: 1.04	138 infections, 149707 patient days	1.04
Q1 2014 - Q4 2014 Result 148 infections, 161317 patient days Rating SIR: 1.09	148 infections, 161317 patient days	1.09
Q1 2013 - Q4 2013 Result 176 infections, 159512 patient days Rating SIR: 1.22	176 infections, 159512 patient days	1.22
Q1 2012 - Q4 2012 Result 154 infections, 161514 patient days Rating SIR: 1.05	154 infections, 161514 patient days	1.05

Adult CLABSI Measure	Result	SIR
Adult Neurosurgical ICU Q1 2024 - Q4 2024 Result 1 infections, 1196 central-line days Rating SIR: 0.74	1 infections, 1196 central-line days	0.74
Description Central Line-associated Bloodstream Infection data in the Adult Neurosurgical ICU Summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 0 infections, 1337 central-line days Rating SIR: 0.00	0 infections, 1337 central-line days	0.00
Q1 2022 - Q4 2022 Result 1 infections, 1171 central-line days Rating SIR: 0.76	1 infections, 1171 central-line days	0.76
Q1 2021 - Q4 2021 Result 1 infections, 1294 central-line days Rating SIR: 0.69	1 infections, 1294 central-line days	0.69
Q1 2019 - Q4 2019 Result 0 infections, 1354 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1354 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2018 - Q4 2018 Result 0 infections, 1309 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1309 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 0 infections, 1490 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1490 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2016 - Q4 2016 Result 3 infections, 2099 central-line days Rating SIR: 1.27	3 infections, 2099 central-line days	1.27
Q1 2015 - Q4 2015 Result 2 infections, 2271 central-line days Rating SIR: 0.35	2 infections, 2271 central-line days	0.35
Q1 2014 - Q4 2014 Result 0 infections, 2048 central-line days Rating SIR: 0.00	0 infections, 2048 central-line days	0.00
Q1 2013 - Q4 2013 Result 0 infections, 1752 central-line days Rating SIR: 0.00	0 infections, 1752 central-line days	0.00
Q1 2012 - Q4 2012 Result 6 infections, 2161 central-line days Rating SIR: 1.11	6 infections, 2161 central-line days	1.11
Adult Medical Cardiac ICU Q1 2024 - Q4 2024 Result 1 infections, 3972 central-line days Rating SIR: 0.22	1 infections, 3972 central-line days	0.22
Description Central Line-associated Bloodstream Infection data in the Adult Medical Cardiac ICU Summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 1 infections, 3927 central-line days Rating SIR: 0.23	1 infections, 3927 central-line days	0.23
Q1 2022 - Q4 2022 Result 2 infections, 4008 central-line days Rating SIR: 0.44	2 infections, 4008 central-line days	0.44
Q1 2021 - Q4 2021 Result 2 infections, 3763 central-line days Rating SIR: 0.47	2 infections, 3763 central-line days	0.47
Q1 2019 - Q4 2019 Result 1 infections, 2399 central-line days Rating SIR: 0.37	1 infections, 2399 central-line days	0.37
Q1 2018 - Q4 2018 Result 2 infections, 2100 central-line days Rating SIR: 0.84	2 infections, 2100 central-line days	0.84
Q1 2017 - Q4 2017 Result 3 infections, 1932 central-line days Rating SIR: 1.38	3 infections, 1932 central-line days	1.38
Q1 2016 - Q4 2016 Result 2 infections, 2100 central-line days Rating SIR: 0.84	2 infections, 2100 central-line days	0.84
Q1 2015 - Q4 2015 Result 5 infections, 1921 central-line days Rating SIR: 1.30	5 infections, 1921 central-line days	1.30
Q1 2014 - Q4 2014 Result 0 infections, 1717 central-line days Rating SIR: 0.00	0 infections, 1717 central-line days	0.00
Q1 2013 - Q4 2013 Result 1 infections, 2063 central-line days Rating SIR: 0.24	1 infections, 2063 central-line days	0.24
Q1 2012 - Q4 2012 Result 4 infections, 1607 central-line days Rating SIR: 1.25	4 infections, 1607 central-line days	1.25
Adult Surgical ICU Q1 2024 - Q4 2024 Result 3 infections, 4069 central-line days Rating SIR: 0.65	3 infections, 4069 central-line days	0.65
Description Central Line-associated Bloodstream Infection data in the Adult Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 0 infections, 3867 central-line days Rating SIR: 0.00	0 infections, 3867 central-line days	0.00
Q1 2022 - Q4 2022 Result 1 infections, 3980 central-line days Rating SIR: 0.22	1 infections, 3980 central-line days	0.22
Q1 2021 - Q4 2021 Result 0 infections, 3346 central-line days Rating SIR: 0.00	0 infections, 3346 central-line days	0.00
Q1 2019 - Q4 2019 Result 4 infections, 4585 central-line days Rating SIR: 0.77	4 infections, 4585 central-line days	0.77
Q1 2018 - Q4 2018 Result 5 infections, 4656 central-line days Rating SIR: 0.95	5 infections, 4656 central-line days	0.95
Q1 2017 - Q4 2017 Result 3 infections, 4148 central-line days Rating SIR: 0.64	3 infections, 4148 central-line days	0.64
Q1 2016 - Q4 2016 Result 5 infections, 3897 central-line days Rating SIR: 1.14	5 infections, 3897 central-line days	1.14
Q1 2015 - Q4 2015 Result 3 infections, 3672 central-line days Rating SIR: 0.36	3 infections, 3672 central-line days	0.36
Q1 2014 - Q4 2014 Result 1 infections, 3401 central-line days Rating SIR: 0.13	1 infections, 3401 central-line days	0.13
Q1 2013 - Q4 2013 Result 7 infections, 3164 central-line days Rating SIR: 0.96	7 infections, 3164 central-line days	0.96
Q1 2012 - Q4 2012 Result 2 infections, 3173 central-line days Rating SIR: 0.27	2 infections, 3173 central-line days	0.27
Q1 2011 - Q4 2011 Result 3 infections, 2935 central-line days Rating SIR: 0.44	3 infections, 2935 central-line days	0.44
Q1 2010 - Q4 2010 Result 8 infections, 3921 central-line days Rating SIR: 0.89	8 infections, 3921 central-line days	0.89
Q1 2009 - Q4 2009 Result 14 infections, 4265 central-line days Rating SIR: 1.43	14 infections, 4265 central-line days	1.43
Q1 2009 - Q2 2009 Result 5 infections, 2273 central-line days Rating SIR: 2.20	5 infections, 2273 central-line days	2.20
Adult Medical ICU Q1 2024 - Q4 2024 Result 3 infections, 3763 central-line days Rating SIR: 0.71	3 infections, 3763 central-line days	0.71
Description Central Line-associated Bloodstream Infection data in the Adult Medical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 1 infections, 3897 central-line days Rating SIR: 0.23	1 infections, 3897 central-line days	0.23
Q1 2022 - Q4 2022 Result 6 infections, 3834 central-line days Rating SIR: 1.39	6 infections, 3834 central-line days	1.39
Q1 2021 - Q4 2021 Result 4 infections, 3574 central-line days Rating SIR: 0.99	4 infections, 3574 central-line days	0.99
Q1 2019 - Q4 2019 Result 2 infections, 3640 central-line days Rating SIR: 0.49	2 infections, 3640 central-line days	0.49
Q1 2018 - Q4 2018 Result 5 infections, 3736 central-line days Rating SIR: 1.19	5 infections, 3736 central-line days	1.19
Q1 2017 - Q4 2017 Result 4 infections, 3508 central-line days Rating SIR: 1.01	4 infections, 3508 central-line days	1.01
Q1 2016 - Q4 2016 Result 2 infections, 4140 central-line days Rating SIR: 0.43	2 infections, 4140 central-line days	0.43
Q1 2015 - Q4 2015 Result 2 infections, 4248 central-line days Rating SIR: 0.18	2 infections, 4248 central-line days	0.18
Q1 2014 - Q4 2014 Result 2 infections, 3735 central-line days Rating SIR: 0.21	2 infections, 3735 central-line days	0.21
Q1 2013 - Q4 2013 Result 14 infections, 3537 central-line days Rating SIR: 1.52	14 infections, 3537 central-line days	1.52
Q1 2012 - Q4 2012 Result 13 infections, 3303 central-line days Rating SIR: 1.51	13 infections, 3303 central-line days	1.51
Q1 2011 - Q4 2011 Result 6 infections, 3025 central-line days Rating SIR: 1.04	6 infections, 3025 central-line days	1.04
Q1 2010 - Q4 2010 Result 8 infections, 2968 central-line days Rating SIR: 1.42	8 infections, 2968 central-line days	1.42
Q1 2009 - Q4 2009 Result 8 infections, 3650 central-line days Rating SIR: 1.15	8 infections, 3650 central-line days	1.15
Q1 2009 - Q2 2009 Result 6 infections, 1816 central-line days Rating SIR: 3.30	6 infections, 1816 central-line days	3.30

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2023 - Q4 2023 Result 1 infections, 1670 central-line days Rating SIR: 0.42	1 infections, 1670 central-line days	0.42
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 1 infections, 1306 central-line days Rating SIR: 0.53	1 infections, 1306 central-line days	0.53
Q1 2021 - Q4 2021 Result 2 infections, 1494 central-line days Rating SIR: 0.93	2 infections, 1494 central-line days	0.93
Q1 2019 - Q4 2019 Result 0 infections, 2498 central-line days Rating SIR: 0.00	0 infections, 2498 central-line days	0.00
Q1 2018 - Q4 2018 Result 5 infections, 2867 central-line days Rating SIR: 1.21	5 infections, 2867 central-line days	1.21
Q1 2017 - Q4 2017 Result 4 infections, 2427 central-line days Rating SIR: 1.15	4 infections, 2427 central-line days	1.15
Q1 2016 - Q4 2016 Result 1 infections, 1917 central-line days Rating SIR: 0.36	1 infections, 1917 central-line days	0.36
Q1 2015 - Q4 2015 Result 0 infections, 1694 central-line days Rating SIR: 0.00	0 infections, 1694 central-line days	0.00
Q1 2014 - Q4 2014 Result 0 infections, 1659 central-line days Rating SIR: 0.00	0 infections, 1659 central-line days	0.00
Q1 2013 - Q4 2013 Result 1 infections, 1508 central-line days Rating SIR: 0.22	1 infections, 1508 central-line days	0.22
Q1 2012 - Q4 2012 Result 3 infections, 1519 central-line days Rating SIR: 0.66	3 infections, 1519 central-line days	0.66
Q1 2011 - Q4 2011 Result 9 infections, 2450 central-line days Rating SIR: 1.22	9 infections, 2450 central-line days	1.22
Q1 2010 - Q4 2010 Result 6 infections, 2015 central-line days Rating SIR: 0.99	6 infections, 2015 central-line days	0.99
Q1 2010 - Q2 2010 Result 4 infections, 1071 central-line days Rating SIR: 1.24	4 infections, 1071 central-line days	1.24

NICU CLABSI Measure	Result	SIR
Level III Neonatal ICU Q1 2024 - Q4 2024 Result 0 infections, 1086 central-line days ¹⁸⁵ Rating SIR: 0.00 ¹⁸⁵	0 infections, 1086 central-line days ¹⁸⁵	0.00 ¹⁸⁵
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 1 infections, 2997 central-line days Rating SIR: 0.22	1 infections, 2997 central-line days	0.22
Q1 2022 - Q4 2022 Result 4 infections, 2766 central-line days Rating SIR: 1.07	4 infections, 2766 central-line days	1.07
Q1 2021 - Q4 2021 Result 1 infections, 2727 central-line days Rating SIR: 0.28	1 infections, 2727 central-line days	0.28
Q1 2019 - Q4 2019 Result 0 infections, 3704 central-line days Rating SIR: 0.00	0 infections, 3704 central-line days	0.00
Q1 2018 - Q4 2018 Result 6 infections, 3476 central-line days Rating SIR: 1.20	6 infections, 3476 central-line days	1.20
Q1 2017 - Q4 2017 Result 4 infections, 4020 central-line days Rating SIR: 0.60	4 infections, 4020 central-line days	0.60
Q1 2016 - Q4 2016 Result 4 infections, 3920 central-line days Rating SIR: 0.71	4 infections, 3920 central-line days	0.71
Q1 2015 - Q4 2015 Result 3 infections, 2974 central-line days Rating SIR: 0.42	3 infections, 2974 central-line days	0.42
Q1 2014 - Q4 2014 Result 2 infections, 2924 central-line days Rating SIR: 0.28	2 infections, 2924 central-line days	0.28
Q1 2013 - Q4 2013 Result 2 infections, 3185 central-line days Rating SIR: 0.26	2 infections, 3185 central-line days	0.26
Q1 2012 - Q4 2012 Result 6 infections, 5386 central-line days Rating SIR: 0.46	6 infections, 5386 central-line days	0.46
Q1 2011 - Q4 2011 Result 3 infections, 4599 central-line days Rating SIR: 0.27	3 infections, 4599 central-line days	0.27
Q1 2010 - Q4 2010 Result 22 infections, 6256 central-line days Rating SIR: 1.34	22 infections, 6256 central-line days	1.34
Q1 2010 - Q2 2010 Result 14 infections, 2981 central-line days Rating SIR: 1.55	14 infections, 2981 central-line days	1.55

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2024 - Q4 2024 Result 13 infections, 1068 procedures Rating SIR: 2.66	13 infections, 1068 procedures	2.66
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 7 infections, 1056 procedures Rating SIR: 1.65	7 infections, 1056 procedures	1.65
Q1 2022 - Q4 2022 Result 9 infections, 1173 procedures Rating SIR: 1.96	9 infections, 1173 procedures	1.96
Q1 2021 - Q4 2021 Result 6 infections, 1227 procedures Rating SIR: 1.26	6 infections, 1227 procedures	1.26
Q1 2020 - Q4 2020 Result 12 infections, 1300 procedures Rating SIR: 2.56	12 infections, 1300 procedures	2.56
Q1 2019 - Q4 2019 Result 11 infections, 1639 procedures Rating SIR: 1.98	11 infections, 1639 procedures	1.98
Q1 2018 - Q4 2018 Result 19 infections, 1980 procedures Rating SIR: 2.86	19 infections, 1980 procedures	2.86
Q1 2017 - Q4 2017 Result 6 infections, 1598 procedures Rating SIR: 1.12	6 infections, 1598 procedures	1.12
Q1 2016 - Q4 2016 Result 6 infections, 1544 procedures Rating SIR: 1.21	6 infections, 1544 procedures	1.21
Q1 2015 - Q4 2015 Result 8 infections, 1803 procedures Rating SIR: 0.67	8 infections, 1803 procedures	0.67
Q1 2014 - Q4 2014 Result 11 infections, 1729 procedures Rating SIR: 0.96	11 infections, 1729 procedures	0.96
Q3 2013 - Q2 2014 Result 9 infections, 1230 procedures Rating SIR: 1.07	9 infections, 1230 procedures	1.07
Q3 2012 - Q2 2013 Result 5 infections, 1285 procedures Rating SIR: 0.58	5 infections, 1285 procedures	0.58
Q3 2011 - Q2 2012 Result 3 infections, 940 procedures Rating SIR: 0.45	3 infections, 940 procedures	0.45
Q3 2010 - Q2 2011 Result 5 infections, 1241 procedures Rating SIR: 0.55	5 infections, 1241 procedures	0.55
Coronary Artery Bypass Graft Surgery Q1 2024 - Q4 2024 Result 2 infections, 177 procedures Rating SIR: 1.09	2 infections, 177 procedures	1.09
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 0 infections, 172 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 172 procedures ¹¹⁷	0.00 ¹¹⁷
Q1 2022 - Q4 2022 Result 1 infections, 155 procedures Rating SIR: 0.57	1 infections, 155 procedures	0.57
Q1 2021 - Q4 2021 Result 2 infections, 160 procedures Rating SIR: 1.33	2 infections, 160 procedures	1.33
Q1 2020 - Q4 2020 Result 1 infections, 171 procedures Rating SIR: 0.55	1 infections, 171 procedures	0.55
Q1 2019 - Q4 2019 Result 2 infections, 200 procedures Rating SIR: 0.95	2 infections, 200 procedures	0.95
Q1 2018 - Q4 2018 Result 1 infections, 197 procedures Rating SIR: 0.52	1 infections, 197 procedures	0.52
Q1 2016 - Q4 2016 Result 0 infections, 111 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 111 procedures ¹⁵³	N/A ¹⁵³
Q1 2015 - Q4 2015 Result 0 infections, 115 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 115 procedures ¹¹⁷	0.00 ¹¹⁷
Q1 2014 - Q4 2014 Result 0 infections, 110 procedures Rating SIR: 0.00	0 infections, 110 procedures	0.00
Q3 2013 - Q2 2014 Result 1 infections, 117 procedures Rating SIR: 0.49	1 infections, 117 procedures	0.49
Q3 2012 - Q2 2013 Result 0 infections, 120 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 120 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2011 - Q2 2012 Result 2 infections, 99 procedures Rating SIR: 1.27	2 infections, 99 procedures	1.27
Q3 2010 - Q2 2011 Result 0 infections, 64 procedures Rating SIR: 0.00	0 infections, 64 procedures	0.00